Anti-Fc Fragment Of IgG Low Affinity IIIa Receptor (FcgR3A) Monoclonal Antibody Homo sapiens (Human) Protein, Antibody, Assaykit, Service

CD16a; CD16-A; FCGR3-A; FCG3; FcgRIII; IGFR3; NA; Neutrophil Antigen; Low affinity immunoglobulin gamma Fc region receptor III-A

Add to Cart Distributors
Overview
Properties
  • Ig Isotype IgG, Clone Number n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Excitation Laser
  • Vol. per test
  • Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  • TraitsLiquid
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Anti-Fc Fragment Of IgG Low Affinity IIIa Receptor (FcgR3A) Monoclonal Antibody Packages (Simulation)
  • Anti-Fc Fragment Of IgG Low Affinity IIIa Receptor (FcgR3A) Monoclonal Antibody Packages (Simulation)
  • Anti-Fc Fragment Of IgG Low Affinity IIIa Receptor (FcgR3A) Monoclonal Antibody Human peripheral blood lymphocytes were stained with 5µg/ml mouse Anti-human FcgR3A Recombinant Antibody (Catalog FAB278Hu08, red histogram) or Isotype control antibody (Catalog IS067-Mu01, green histogram), followed by 1µg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Usage

Flow cytometry: 5µg/ml;
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Giveaways

Citations

  • Specific Plasma Autoantibody Reactivity in Myelodysplastic SyndromesNature: Source
  • Elevated Membrane and Soluble CD64: A Novel Marker Reflecting Altered FcγR Function and Disease in Early Rheumatoid Arthritis That Can Be Regulated by Anti-Rheumatic TreatmentPubMed: 26406605

Recommend products